GlassScriptPhysician profile
Michael M Hall
NPI 1780688366
$3,615.31
in general payments reported to CMS, 2019-2025
7 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.82 · 2020: $37.82 · 2021: $87.88 · 2022: $108 · 2023: $1,871 · 2024: $1,255 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,375 · Consulting Fee: $1,225 · Food and Beverage: $408 · Travel and Lodging: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,375.00 |
| Consulting Fee | $1,225.00 |
| Food and Beverage | $408.31 |
| Travel and Lodging | $323.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $2,200.00 | 2023-2024 | Acuson Sequoia Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System |
| Verathon INC. | $400.00 | 2023 | Npd Clinical Study |
| Indivior INC. | $357.94 | 2019-2025 | Sublocade |
| Regeneron Pharmaceuticals, INC. | $323.68 | 2024 | |
| Alkermes, INC. | $231.29 | 2021-2025 | Vivitrol, Vivitrol |
| Braeburn INC. | $56.37 | 2023-2024 | Brixadi |
| Orexo US, INC. | $46.03 | 2020-2023 | Zubsolv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.